Healthcare provider profile · identity verified

Yudith Lopez, APRN

Nurse Practitioner · MIAMI, FL · NPI 1356013692

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	472	111
Vitamin D2	Ergocalciferol (Vitamin D2)	434	81
Gabapentin	Gabapentin	365	62
Omeprazole	Omeprazole	333	64
Metformin Hcl	Metformin Hcl	326	72
Farxiga	Dapagliflozin Propanediol	244	38
Levothyroxine Sodium	Levothyroxine Sodium	206	43
Montelukast Sodium	Montelukast Sodium	201	37
Diclofenac Sodium	Diclofenac Sodium	198	52
Famotidine	Famotidine	184	43
Losartan Potassium	Losartan Potassium	179	62
Memantine Hcl	Memantine Hcl	172	34
Amlodipine Besylate	Amlodipine Besylate	157	51
Hydrochlorothiazide	Hydrochlorothiazide	156	46
Rosuvastatin Calcium	Rosuvastatin Calcium	155	40
Pantoprazole Sodium	Pantoprazole Sodium	146	35
Alendronate Sodium	Alendronate Sodium	142	30
Glipizide	Glipizide	142	33
Lisinopril	Lisinopril	139	39
Hydroxyzine Hcl	Hydroxyzine Hcl	134	36
Ciclopirox	Ciclopirox	132	29
Clopidogrel	Clopidogrel Bisulfate	113	26
Ciclopirox	Ciclopirox Olamine	108	34
Meclizine Hcl	Meclizine Hcl	103	26
Azithromycin	Azithromycin	102	75
Simvastatin	Simvastatin	97	24
Metoclopramide Hcl	Metoclopramide Hcl	91	34
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	89	17
Fluticasone Propionate	Fluticasone Propionate	87	28
Ammonium Lactate	Ammonium Lactate	86	29
Albuterol Sulfate Hfa	Albuterol Sulfate	85	25
Eliquis	Apixaban	84	12
Escitalopram Oxalate	Escitalopram Oxalate	83	24
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	81	31
Tamsulosin Hcl	Tamsulosin Hcl	78	21
Folic Acid	Folic Acid	76	14
Pioglitazone Hcl	Pioglitazone Hcl	76	18
Ozempic	Semaglutide	72	12
Tizanidine Hcl	Tizanidine Hcl	72	45
Metoprolol Tartrate	Metoprolol Tartrate	71	20
Januvia	Sitagliptin Phosphate	68	suppressed
Methocarbamol	Methocarbamol	66	52
Linzess	Linaclotide	65	21
Nystatin	Nystatin	65	23
Ibuprofen	Ibuprofen	62	36
Metoprolol Succinate	Metoprolol Succinate	62	23
Bumetanide	Bumetanide	61	13
Dicyclomine Hcl	Dicyclomine Hcl	61	30
Furosemide	Furosemide	61	15
Sertraline Hcl	Sertraline Hcl	59	11
Triamcinolone Acetonide	Triamcinolone Acetonide	59	22
Alprazolam	Alprazolam	58	13
Trazodone Hcl	Trazodone Hcl	58	14
Mirtazapine	Mirtazapine	54	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	50	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	49	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	47	suppressed
Allopurinol	Allopurinol	45	12
Carvedilol	Carvedilol	45	15
Atenolol	Atenolol	44	13
Meloxicam	Meloxicam	44	32
Quetiapine Fumarate	Quetiapine Fumarate	44	suppressed
Enalapril Maleate	Enalapril Maleate	43	13
Donepezil Hcl	Donepezil Hcl	41	suppressed
Tadalafil	Tadalafil	40	suppressed
Latanoprost	Latanoprost	39	suppressed
Metformin Hcl Er	Metformin Hcl	39	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	39	25
Clonazepam	Clonazepam	38	suppressed
Glipizide Er	Glipizide	38	suppressed
Pregabalin	Pregabalin	38	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	37	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	36	31
Clonidine Hcl	Clonidine Hcl	36	suppressed
Synthroid	Levothyroxine Sodium	36	suppressed
Benzonatate	Benzonatate	35	26
Esomeprazole Magnesium	Esomeprazole Magnesium	35	11
Finasteride	Finasteride	35	suppressed
Azelastine-Fluticasone	Azelastine/Fluticasone	33	12
Methylprednisolone	Methylprednisolone	33	23
Dexamethasone	Dexamethasone	32	13
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Mupirocin	Mupirocin	30	22
Fluconazole	Fluconazole	29	16
Piroxicam	Piroxicam	29	18
Potassium Chloride	Potassium Chloride	29	suppressed
Jardiance	Empagliflozin	28	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	27	suppressed
Nifedipine Er	Nifedipine	27	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	27	suppressed
Temazepam	Temazepam	27	suppressed
Clotrimazole	Clotrimazole	26	13
Ibu	Ibuprofen	26	12
Nitrofurantoin	Nitrofurantoin Macrocrystal	26	25
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	25
Cephalexin	Cephalexin	25	21
Insulin Lispro Kwikpen U-100	Insulin Lispro	25	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	25	suppressed
Ondansetron Hcl	Ondansetron Hcl	25	15
Sildenafil Citrate	Sildenafil Citrate	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	24	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Prednisone	Prednisone	24	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Ondansetron Odt	Ondansetron	23	17
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	22	suppressed
Brilinta	Ticagrelor	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Spironolactone	Spironolactone	21	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Fenofibrate	Fenofibrate,micronized	20	suppressed
Valsartan	Valsartan	20	suppressed
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	19	suppressed
Gemfibrozil	Gemfibrozil	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Loperamide	Loperamide Hcl	19	17
Naproxen	Naproxen	19	suppressed
Repaglinide	Repaglinide	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Vascepa	Icosapent Ethyl	19	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Glimepiride	Glimepiride	17	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	17	suppressed
Lubiprostone	Lubiprostone	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Humalog	Insulin Lispro	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Anastrozole	Anastrozole	15	suppressed
Baclofen	Baclofen	15	12
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Hydrocortisone-Acetic Acid	Hydrocortisone/Acetic Acid	15	14
Lactulose	Lactulose	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Mupirocin	Mupirocin Calcium	14	14
Repatha Sureclick	Evolocumab	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Duloxetine Hcl	Duloxetine Hcl	13	suppressed
Levofloxacin	Levofloxacin	13	12
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Synjardy	Empagliflozin/Metformin Hcl	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	12	suppressed
Ciprofloxacin-Dexamethasone	Ciprofloxacin Hcl/Dexameth	12	12
Penicillin V Potassium	Penicillin V Potassium	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	12
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Cyproheptadine Hcl	Cyproheptadine Hcl	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Pentoxifylline	Pentoxifylline	11	suppressed
Pravastatin Sodium	Pravastatin Sodium	11	suppressed
Ssd	Silver Sulfadiazine	11	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error